| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | H. William Kelly | |
| P2860 | cites work | Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler | Q28365894 |
| Transcriptional potencies of inhaled glucocorticoids. | Q31409970 | ||
| Budesonide fatty-acid esterification: a novel mechanism prolonging binding to airway tissue. Review of available data | Q32143825 | ||
| Systemic adverse effects of inhaled corticosteroid therapy: A systematic review and meta-analysis | Q33634936 | ||
| Pharmacodynamics and pharmacokinetics of budesonide: a new nebulized corticosteroid | Q33750680 | ||
| Safety of inhaled and intranasal corticosteroids: lessons for the new millennium | Q33983915 | ||
| Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma | Q34102503 | ||
| Clinical considerations in the use of inhaled corticosteroids for asthma | Q34186812 | ||
| Inhaled mometasone furoate: a review of its use in adults and adolescents with persistent asthma | Q34340426 | ||
| Pharmacokinetics and systemic effects of inhaled fluticasone propionate in healthy subjects | Q36093906 | ||
| Anti-inflammatory properties of fluticasone propionate | Q40445813 | ||
| A comparison of the efficacy and safety of inhaled corticosteroids in asthma | Q41559651 | ||
| Comparison of inhaled corticosteroids | Q41718750 | ||
| Therapeutic ratio of inhaled corticosteroids in adult asthma. A dose-range comparison between fluticasone propionate and budesonide, measuring their effect on bronchial hyperresponsiveness and adrenal cortex function | Q43407227 | ||
| Asthma stability after oral prednisone: a clinical model for comparing inhaled steroid potency | Q43774792 | ||
| Significant variability in response to inhaled corticosteroids for persistent asthma | Q43920193 | ||
| Systemic effect comparisons of six inhaled corticosteroid preparations | Q43997159 | ||
| Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group | Q44104022 | ||
| Systemic bioavailability and potency of high-dose inhaled corticosteroids: a comparison of four inhaler devices and three drugs in healthy adult volunteers | Q47603181 | ||
| Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant | Q48737414 | ||
| Prolonged airway activity and improved selectivity of budesonide possibly due to esterification. | Q50758361 | ||
| Biological esterification of steroids. | Q52564026 | ||
| Comparison of pharmacokinetics and systemic effects of inhaled fluticasone propionate in patients with asthma and healthy volunteers: a randomised crossover study | Q57138667 | ||
| Comparative study of budesonide as a nebulized suspension vs pressurized metered-dose inhaler in adult asthmatics | Q57638370 | ||
| Pulmonary targeting of liposomal triamcinolone acetonide phosphate | Q71862566 | ||
| Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma | Q72123963 | ||
| Lung deposition of budesonide from Turbuhaler is twice that from a pressurized metered-dose inhaler P-MDI | Q72426713 | ||
| Dose-response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma | Q73028987 | ||
| A randomized, double-blind dose reduction study to compare the minimal effective dose of budesonide Turbuhaler and fluticasone propionate Diskhaler | Q73493368 | ||
| Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes | Q73833588 | ||
| Pharmacokinetic/pharmacodynamic aspects of aerosol therapy using glucocorticoids as a model | Q74321636 | ||
| Establishing a therapeutic index for the inhaled corticosteroids: part I. Pharmacokinetic/pharmacodynamic comparison of the inhaled corticosteroids | Q77499004 | ||
| Time to onset of effect of fluticasone propionate in patients with asthma | Q77755091 | ||
| Adrenal effects and pharmacokinetics of CFC-free beclomethasone dipropionate: a 14-day dose-response study | Q77800101 | ||
| Importance of drug-device interaction in determining systemic effects of inhaled corticosteroids | Q77924737 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | immunology | Q101929 |
| P304 | page(s) | 326-34; quiz 334-5, 404 | |
| P577 | publication date | 2003-10-01 | |
| P1433 | published in | Annals of Allergy, Asthma & Immunology | Q13429696 |
| P1476 | title | Pharmaceutical characteristics that influence the clinical efficacy of inhaled corticosteroids | |
| P478 | volume | 91 |
| Q35876418 | Ciclesonide in persistent asthma: the evidence of its therapeutic value. |
| Q33300580 | Ciclesonide uptake and metabolism in human alveolar type II epithelial cells (A549) |
| Q37406595 | Comparison of inhaled corticosteroids: an update |
| Q37367742 | Controlling for drug dose in systematic review and meta-analysis: a case study of the effect of antidepressant dose |
| Q46219373 | Effect of intratonsillar injection of steroids on the palatine tonsils of rabbits. |
| Q22306079 | Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes |
| Q92004369 | Efficacy of ciclesonide in the treatment of patients with asthma exacerbation |
| Q45978217 | High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. |
| Q34995731 | Inhaled corticosteroids in childhood asthma: the story continues |
| Q37556510 | Mometasone furoate: an inhaled glucocorticoid for the management of asthma in adults and children |
| Q36755463 | Randomised, crossover clinical trial, in healthy volunteers, to compare the systemic availability of two topical intranasal budesonide formulations |
| Q35814437 | Targeting Syk as a treatment for allergic and autoimmune disorders |
| Q36579819 | The systemic safety of inhaled corticosteroid therapy: a focus on ciclesonide |
| Q45006395 | The therapeutic index in asthma: how should it be defined? |
Search more.